2 studies found for:    9603539 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
2 Completed Biomarkers for Cardiovascular Disease
Condition: Coronary Artery Disease
Intervention:

Indicates status has not been verified in more than two years